Browse > Article
http://dx.doi.org/10.4333/KPS.2006.36.5.299

Deformable Liposomes for Topical Skin Delivery of Arbutin  

Bian, Shengjie (College of Pharmacy, Pusan National University)
Choi, Min-Koo (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Lin, Hongxia (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Zheng, Junmin (Department of Pharmaceutics, Shenyang Pharmaceutical University)
Chung, Suk-Jae (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Shim, Chang-Koo (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Kim, Dae-Duk (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University)
Publication Information
Journal of Pharmaceutical Investigation / v.36, no.5, 2006 , pp. 299-304 More about this Journal
Abstract
The aim of this study was to investigate the effect of deformable liposomes with sodium cholate on the skin permeation and skin deposition of arbutin, a hydrophilic skin-whitening agent. Various compositions of liposomes were prepared by the extrusion method. Particle size distribution and entrapment efficiency were determined by the laser light scattering and the gel permeation chromatography, respectively. The in vitro rat skin permeation and deposition of arbutin in various skin layers were investigated using the Keshary-Chien diffusion cells at $37^{\circ}C$. The average particle size of the deformable liposomes ranged from 217.4 to 117.4 nm, depending on the composition. The entrapment efficiency was dependent on surfactant concentration and loading dose of arbutin. The permeation rate of 5% arbutin in deformable liposomes was $8.91({\pm}1.33){\mu}g/cm^2/h$, and was not significantly different from 5% arbutin aqueous solution $[9.82({\m}0.86){\mu}g/cm^2/h]$. The deposition of arbutin was $43.34({\pm}12.13)$ and $16.99({\pm}7.83){\mu}g/cm^2$ in stratum corneum layer and epidermis/dermis layer, respectively, after 12 h of permeation study. These results are consistent with several earlier studies for the localization effect of liposomal formulations in stratum corneum, and demonstrated the feasibility of the deformable liposomes as a promising carrier for the skin deposition of hydrophilic skin-whitening compounds.
Keywords
Arbutin; Deformable liposomes; Topical delivery; Skin permeation; Skin deposition;
Citations & Related Records
연도 인용수 순위
  • Reference
1 C.E. Griffiths, M.T. Goldfarb, L.J. Finkel, V. Roulia, M. Bonawitz, T.A. Hamilton, C.N. Ellis and J.J. Voorhees, Topical tretinoin (retinoic acid) treatment of hyperpigmented lesions associated with photoaging in Chinese and Japanese patients: a vehicle-controlled trial, J. Am. Acad. Dermatol., 30, 76-84 (1994)   DOI   ScienceOn
2 K. Maeda and M. Fukuda, Arbutin: mechanism of its depigmentation action in human melanocyte culture, J. Pharmacol. Exper. Ther., 276, 765-769 (1996)
3 M.H. Schmid and H.C. Korting, Therapeutic progress with topical liposome drugs for skin disease, Adv. Drug Deliv. Rev., 18, 335-342 (1996)   DOI   ScienceOn
4 E. Bernard, J.L. Dubois and J. Wepierre, Percutaneous absorp- tion of a new antiandrogen included in liposomes or in solution, Int. J. Pharm., 126, 235-243 (1995)   DOI   ScienceOn
5 M. Kirjavainen, A. Urtti, R. Valjakka-Koskela, J. Kiesvaara and J. Monkkonen, Liposome-skin interactions and their effects on the skin permeation of drugs, Eur. J. Pharm. Sci., 7, 279-286 (1999)   DOI   ScienceOn
6 M.H. Schmid and H.C. Korting, Liposomes: A drug carrier system for topical treatment in dermatology, Crit. Rev. Ther. Drug Carrier Sys., 11, 97-118 (1994)
7 H. Nakayama, T. Ebihara, N. Satoh and T. Jinnai, Depigmentation agents: In Cosmeceuticals. Marcel Dekker, New York, U.S.A., pp.123-144 (2000)
8 K. Jimbow, T.B. Fitzpatrick and M.M. Wick, Biochemistry and physiology of melanin pigmentation: In Physiology, Biochemistry and Molecular Biology of the Skin. Oxford University Press, Oxford, U.K., pp. 873-909 (1991)
9 H. Takashima, H. Nomura, Y. Imai and H. Mima, Ascorbic acid esters and skin pigmentation, Am. Perf. Cosmetol., 86, 29-36 (1971)
10 E.V. Curto, C. Kwong, H. Hermersdorfer, H. Glatt, C. Santis, V. Virador, J.V. Hearing and T.P. Dooley, Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors, Biochem. Pharmacol., 57, 663-672 (1999)   DOI   ScienceOn
11 J. Cabanes, S. Chazarra and F. Garcia-Carmona, Kojic acid, a cosmetic skin whitening agent, is the low-binding inhibition of catecholase activity of tyrosinase, J. Pharm. Pharmacol., 46, 982-985 (1994)   DOI   ScienceOn
12 M.E. Planas, P. Gonzalez, L. Rodriguez, S. Sanchez and G. Cevc, Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier and prolongation of local pain insensitivity by anesthetic liposomes, Anesth. Analg., 75, 615-621 (1992)
13 P.L. Honeywell-Nguyen, P.M. Frederik, P.H.H. Bomans, H.E. Junginger and J.A. Bouwstra, Transdermal delivery of pergolide from surfactant-based elastic and rigid vesicles: characterization and in vitro transport studies, Pharm. Res., 19, 991-997 (2002)   DOI   ScienceOn
14 G. Cevc and G. Blume, Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force, Biochim. Biophys. Acta, 1104, 226-232 (1992)   DOI   ScienceOn
15 G. Cevc, G. Blume, A. Schatzlein, D. Gebauer and A. Paul, The skin: a pathway for systemic treatment with patches and lipid-based agent carriers, Adv. Drug Del. Rev., 18, 349-378 (1996)   DOI   ScienceOn
16 G.M.M. El Maghraby, A.C. Williams and B.W. Barry, Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration, Int. J. Pharm., 196, 63-74 (2000)   DOI   ScienceOn
17 C. Valenta and M. Janisch, Permeation of cyproterone acetate through pig skin from different vehicles with phospholipids, Int. J. Pharm., 258, 133-139 (2003)   DOI   ScienceOn
18 M. Trotta, E. Peira, M.E. Carlotti and M. Gallarate, Defor- mable liposomes for dermal administration of methothexate, Int. J. Pharm., 270, 119-125 (2004)   DOI   ScienceOn
19 G. Cevc, D. Gebauer, J. Stieber, A. Schatzlein and G. Bume, Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin, Biochim. Biophys. Acta, 1368, 201-215 (1998)   DOI   ScienceOn
20 M. Kirjavainen, A. Urtti and I. Jaaskelainen, Interaction of liposomes with human skin in vitro- the influence of lipid composition and structure, Biochim. Biophy. Acta, 1304, 179-189 (1996)   DOI   ScienceOn
21 J.L. Bolognia, S.A. Sodi, M.P. Osber and J.M. Pawelek, Enhancement of the depigmentary effect of hydroquinone by cystamine and butionine sulfoximine, Br. J. Dermatol., 133, 349-357 (1995)   DOI   ScienceOn
22 F.P. Bonina, L. Montenegro and N. Serofani, Effects of phopholipid based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate, J. Control. Release, 34, 53-63 (1995)   DOI   ScienceOn
23 G. Cevc, A. Schatzlein and G. Blume, Transdermal drug carriers: Basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides, J. Control. Release, 36, 3-16 (1995)   DOI   ScienceOn
24 G. Cevc, G. Blume and A. Schatzlein, Transfersomes-mediated transepidermal delivery improves the region-specificity and biological activity of corticosteroids in vivo, J. Control. Release, 45, 211-226 (1997)   DOI   ScienceOn
25 E. Touitou, F.L. Schaffer, N. Dayan, F. Althaique and F. Riccieri, Modulation of caffeine delivery by carrier design: liposomes versus permeation enhancers, Int. J. Pharm., 103, 131-136 (1994)   DOI   ScienceOn